BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15816560)

  • 1. Caveolin-1 down-regulation activates estrogen receptor alpha expression and leads to 17beta-estradiol-stimulated mammary tumorigenesis.
    Zhang X; Shen P; Coleman M; Zou W; Loggie BW; Smith LM; Wang Z
    Anticancer Res; 2005; 25(1A):369-75. PubMed ID: 15816560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RbAp46 inhibits estrogen-stimulated progression of neoplastigenic breast epithelial cells.
    Zhang TF; Yu SQ; Wang ZY
    Anticancer Res; 2007; 27(5A):3205-9. PubMed ID: 17970062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 haploinsufficiency leads to partial transformation of human breast epithelial cells.
    Zou W; McDaneld L; Smith LM
    Anticancer Res; 2003; 23(6C):4581-6. PubMed ID: 14981899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of mammary epithelial cells by 3-phosphoinositide- dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1.
    Xie Z; Zeng X; Waldman T; Glazer RI
    Cancer Res; 2003 Sep; 63(17):5370-5. PubMed ID: 14500370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers.
    Sotgia F; Rui H; Bonuccelli G; Mercier I; Pestell RG; Lisanti MP
    Cancer Res; 2006 Nov; 66(22):10647-51. PubMed ID: 17108100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells.
    Lee SW; Reimer CL; Oh P; Campbell DB; Schnitzer JE
    Oncogene; 1998 Mar; 16(11):1391-7. PubMed ID: 9525738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species.
    Park SA; Na HK; Kim EH; Cha YN; Surh YJ
    Cancer Res; 2009 Mar; 69(6):2416-24. PubMed ID: 19276383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of estrogen receptor alpha and beta expression in carcinogen-induced mammary gland tumors of rats.
    Kang JS; Jung NJ; Kim S; Kim DJ; Jang DD; Yang KH
    Eksp Onkol; 2004 Mar; 26(1):31-5. PubMed ID: 15112577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis.
    Medina D; Kittrell FS; Hill J; Shepard A; Thordarson G; Brown P
    Cancer Res; 2005 Apr; 65(8):3493-6. PubMed ID: 15833886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells.
    Fotovati A; Fujii T; Yamaguchi M; Kage M; Shirouzu K; Oie S; Basaki Y; Ono M; Yamana H; Kuwano M
    Clin Cancer Res; 2006 May; 12(10):3010-8. PubMed ID: 16707596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression of Rb associated protein 46 (RbAp46) reverts transformed phenotypes of breast cancer cells.
    Zhang TF; Yu SQ; Deuel TF; Wang ZY
    Anticancer Res; 2003; 23(5A):3735-40. PubMed ID: 14666671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
    Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells.
    Russo J; Fernandez SV; Russo PA; Fernbaugh R; Sheriff FS; Lareef HM; Garber J; Russo IH
    FASEB J; 2006 Aug; 20(10):1622-34. PubMed ID: 16873885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen-mediated tyrosine phosphorylation of caveolin-1 and its effect on the oestrogen receptor localisation: an in vivo study.
    Kiss AL; Turi A; Müllner N; Kovács E; Botos E; Greger A
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):128-37. PubMed ID: 16368181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hydrogen peroxide (H2O2) and methyl-beta-cyclodextrin (MPCD) down regulate caveolin expression in human lens epithelial cells (HLECs)].
    Jun HY; Yao K; Ma J; Li HW; Tang XJ
    Mol Biol (Mosk); 2007; 41(6):994-1001. PubMed ID: 18318117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.
    Santen R; Cavalieri E; Rogan E; Russo J; Guttenplan J; Ingle J; Yue W
    Ann N Y Acad Sci; 2009 Feb; 1155():132-40. PubMed ID: 19250200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.